Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-06 4:34 pm Purchase |
2023-08-01 | 13G | Renovaro Biosciences Inc. RENB |
Abildgaard Ole | 10,162,447 13.900% |
5,154,285 (+102.92%) |
Filing History |
| 2023-10-06 4:30 pm Purchase |
2023-06-26 | 13G | Renovaro Biosciences Inc. RENB |
Abildgaard Ole | 5,008,162 7.700% |
5,008,162 (New Position) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2018-02-16 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 17,545,283 48.500% |
12,243,805 (+230.95%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2018-10-30 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 17,545,283 48.500% |
12,243,805 (+230.95%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2018-12-31 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,814,163 48.500% |
13,512,685 (+254.89%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2019-07-30 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 22,445,397 48.500% |
17,143,919 (+323.38%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2020-05-29 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 8,409,170 18.100% |
3,107,692 (+58.62%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2020-07-08 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 8,409,170 18.100% |
3,107,692 (+58.62%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2020-10-28 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 8,298,170 17.800% |
2,996,692 (+56.53%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2021-12-14 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 9,177,536 17.600% |
3,876,058 (+73.11%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2022-06-24 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 17,739,909 33.500% |
12,438,431 (+234.62%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2022-10-13 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,956,376 34.200% |
13,654,898 (+257.57%) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2020-12-14 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 9,263,436 19.800% |
9,263,436 (New Position) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2022-04-15 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 5,301,478 10.000% |
5,301,478 (New Position) |
Filing History |
| 2023-05-19 5:00 pm Purchase |
2023-04-06 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,956,376 34.000% |
18,956,376 (New Position) |
Filing History |